FDA
approval
· 2026-03-02
FDA Approved: IMODIUM MULTI-SYMPTOM RELIEF — Supplemental Application (Kenvue Brands LLC)
Summary
The FDA approved a supplemental application to expand the labeling for Imodium Multi-Symptom Relief, a combination product of loperamide hydrochloride and dimet…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE)